Minimally Invasive Cardiac Aortic Valve Surgery is a minimally invasive interventional treatment option for patients with advanced/high risk aortic valve disease. Minimally Invasive Cardiac Aortic Valve Surgery, or Transcatheter Aortic Valve Replacement, is also known as TAVI surgery. The procedure involves the use of endoluminal catheter technology to replace the diseased valve by loading a prosthetic valve into the catheter system and delivering the prosthetic valve through the peripheral vasculature or apical pathway to release the valve in the aortic valve position. Minimally invasive cardiac aortic valve surgery avoids the risk factors of cardiac arrest associated with traditional aortic valve replacement surgery, which requires an open chest, and greatly reduces the risk of surgery. According to the ACC/AHA guidelines (American College of Cardiology), TAVI is recommended for high-risk patients who cannot tolerate surgical treatment or who are at greater risk for surgical intervention.